- Tumors1000
- Pathologic Processes951
- Nervous System Diseases861
- Pathology699
- Cancer669
Any
<10 miles
<30 miles
<50 miles
<70 miles
Filter Results
Condition
- Tumors1000
- Pathologic Processes951
- Nervous System Diseases861
- Pathology699
- Cancer669
Where are you looking?
How far are you willing to travel?Any
How old are you?
Trial Status
Recruiting statusPlacebo
Recruiting
Waitlist Available
Administration Type
Trial Phase
Biomarkers
Stage of Disease
- HER2 negative
- PD-L1 positive
- ER positive
- HER2 positive
- EGFR positive
- PD-L1 negative
- EGFR negative
- PR positive
- ALK negative
- KRAS positive
- ER negative
- PR negative
- BRAF positive
- BRAF negative
- CD20 positive
- ALK positive
- ROS1 negative
- BRCA1 positive
- HLA positive
- p16 positive
- BRCA2 positive
- HLA-A positive
- MET positive
- MYC positive
- PIK3CA positive
- RET positive
- HR positive
- IDH positive
- ROS1 positive
- TP53 positive
- IDH negative
- p16 negative
- BCL2 positive
- CD19 positive
- MET negative
- MSS positive
- ANA positive
- BCL6 positive
- BCR-ABL1 positive
- NRAS positive
- PALB2 positive
- RET negative
- TP53 negative
- dMMR positive
- BRCA1 negative
- CFTR positive
- HBsAg positive
- HPV negative
- KRAS negative
- NTRK positive
- BRCA2 negative
- COL7A1 positive
- Ex19del positive
- HLA negative
- HLA-A negative
- L858R positive
- MMR negative
- MSI-H positive
- NTRK negative
- PTEN positive
- RB1 positive
- TTR positive
- anti-dsDNA positive
- ctDNA positive
- ABCA4 positive
- BRCA positive
- CCND1 positive
- CD5 positive
- FGFR2 positive
- HPV positive
- MDM2 positive
- MGMT negative
- MMR positive
- NF1 positive
- RAS positive
- RB1 negative
- T790M positive
- TROP2 negative
- TROP2 positive
- pMMR positive
- APOL1 positive
- APP positive
- C5 positive
- DLL3 positive
- EBV positive
- FGFR3 positive
- FMR1 positive
- GPC3 positive
- HRAS positive
- MGMT positive
- MSI-H negative
- NF2 positive
- NRAS negative
- PSEN1 positive
- PSEN2 positive
- Philadelphia chromosome negative
- Philadelphia chromosome positive
- PiZZ positive
- RAS negative
- RF positive
- RHO positive
- dMMR negative
- p53 positive
- 11q negative
- 11q positive
- AGXT positive
- AKT negative
- ALPL positive
- ARID1A positive
- ATM positive
- Aβ1-42 positive
- CD23 positive
- CD30 positive
- CDK4 positive
- CLDN18.2 positive
- COL1A1 positive
- COL1A2 positive
- DMD positive
- EBV DNA positive
- ER or PR positive
- ER/PR positive
- FLT3 negative
- FLT3 positive
- FOXO1 fusion negative
- FVIII positive
- G719X positive
- GLA positive
- GRN positive
- HBB positive
- HBV DNA negative
- HEXA positive
- HEXB positive
- HPV16 positive
- HR negative
- HTT positive
- HbSS positive
- IGHV negative
- IgHV positive
- JAK2 positive
- KIT positive
- Ki67 positive
- L861Q positive
- MLH1 positive
- MSH2 positive
- MSH6 positive
- MSI negative
- MSS negative
- MTAP positive
- MYC negative
- NPM1 positive
- NY-ESO-1 positive
- PDE6A positive
- PDE6B positive
- PIK3CA negative
- PIK3CD positive
- PIK3R1 positive
- PKLR positive
- PMM2 positive
- PMS2 positive
- PTCH1 positive
- PTEN negative
- Ph positive
- RAF positive
- S768I positive
- SMN1 positive
- SPINK5 positive
- TTR negative
- UGT1A1 positive
- anti-AChR positive
- anti-MuSK positive
- anti-PLA2R positive
- anti-Ro autoantibodies positive
- anti-Ro/SSA positive
- anti-Sm positive
- anti-Smith positive
- del(17p) negative
- dsDNA positive
- other sickle cell syndrome variants positive
- t(11;14) positive
- β-thalassemia positive
- 11q del negative
- 12 negative
- 12 positive
- 13q del negative
- 13q negative
- 13q positive
- 16p11.2 deletion positive
- 17p negative
- 17p positive
- 17p13 deletion negative
- 19q negative
- 19q positive
- 1p negative
- 1p positive
- 1p/19q co-deletion positive
- 1p/19q loss positive
- 1p36 deletion positive
- 22q13.3 deletion positive
- 46 XX karyotype positive
- 5q SMA positive
- Gleason Score 10
- Gleason Score 6
- Gleason Score 7
- Gleason Score 8
- Gleason Score 9
- Grade 1
- Grade 2
- Grade 3
- Grade 4
- Stage IV
- Stage III
- Stage II
- Stage I
- 1927nm Fractional Thulium Laser Treatment
- Adjuvant Therapy (except reconstruction)
- Anti-HER2 Therapy
- Anti-Seizure Medications (up to 2 types)
- Any Treatment for Pancreatic Cancer
- At least one prior tumor-directed therapy
- Avoidance of Activities That Cause Joint Pain
- Beovu
- Biologic Anti-Neoplastic Agent
- Branch Retinal Vein Occlusion (BRVO)
Trial Status
Recruiting statusPlacebo
Recruiting
Waitlist Available
Administration Type
Trial Phase
Biomarkers
Stage of Disease
5589 trials
1
2
3
…50